MarketCap
Facebook
X
TelegramQuarterly report 2024-Q2
added 08-01-2024
Bausch Health Companies Shares 2011-2025 | BHC
Annual Shares Bausch Health Companies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 365 M | 362 M | 359 M | 355 M | 352 M | 350 M | 350 M | 347 M | 347 M | 335 M | 321 M | 305 M | 305 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 365 M | 305 M | 343 M |
Quarterly Shares Bausch Health Companies
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 368 M | 367 M | 365 M | 365 M | 365 M | 363 M | 362 M | 362 M | 362 M | 361 M | 359 M | 360 M | 359 M | 357 M | 355 M | 356 M | 355 M | 353 M | 353 M | 352 M | 352 M | 351 M | 350 M | 352 M | 351 M | 351 M | 349 M | 350 M | 350 M | 350 M | 348 M | 350 M | 345 M | 345 M | 343 M | 345 M | 344 M | 337 M | 334 M | 335 M | 335 M | 335 M | 333 M | 334 M | 308 M | 306 M | 304 M | 304 M | 305 M | 308 M | 306 M | 303 M | 303 M | 304 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 368 M | 303 M | 343 M |
Shares of other stocks in the Drug manufacturers industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
25.6 M | - | - | $ 142 M |  USA |
 |
Assertio Holdings
ASRT
|
71 M | $ 0.76 | -0.88 % | $ 54 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
46.3 M | - | - | $ 754 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
25.8 M | - | 7.5 % | $ 6.35 M | USA |
 |
Canopy Growth Corporation
CGC
|
108 M | $ 1.69 | -2.88 % | $ 182 M |  Canada |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
150 M | - | 0.86 % | $ 117 M | USA |
 |
Agile Therapeutics
AGRX
|
2.16 M | - | 10.11 % | $ 58.2 M | USA |
 |
Cronos Group
CRON
|
350 M | $ 3.13 | -4.32 % | $ 1.72 B | Canada |
 |
Aurora Cannabis
ACB
|
169 M | $ 5.26 | -2.66 % | $ 86.3 M | Canada |
 |
Catalent
CTLT
|
181 M | - | - | $ 11.5 B | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
50.8 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
127 M | - | 2.45 % | $ 38.1 M | Canada |
 |
DURECT Corporation
DRRX
|
26.3 M | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
12.9 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
235 M | - | - | $ 28.9 M |  Irlanda |
 |
Emergent BioSolutions
EBS
|
51.2 M | $ 11.73 | 2.71 % | $ 601 M | USA |
 |
Evoke Pharma
EVOK
|
3.34 M | $ 10.96 | 0.09 % | $ 36.6 M | USA |
 |
Athenex
ATNX
|
6.54 M | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
95.1 M | $ 21.44 | 0.37 % | $ 2.04 B |  France |
 |
Evolus
EOLS
|
62 M | $ 7.21 | 2.34 % | $ 447 M | USA |
 |
Harrow Health
HROW
|
32.6 M | $ 46.92 | -0.31 % | $ 1.53 B | USA |
 |
China Pharma Holdings
CPHI
|
17.5 M | $ 1.45 | -6.69 % | $ 25.3 M |  China |
 |
Lannett Company
LCI
|
40.4 M | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
256 M | $ 1.87 | -2.51 % | $ 402 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
14.1 M | $ 2.72 | 7.58 % | $ 38.2 M | USA |
 |
Organogenesis Holdings
ORGO
|
132 M | $ 4.92 | 2.07 % | $ 648 M | USA |
 |
Pacira BioSciences
PCRX
|
46.2 M | $ 26.69 | 1.52 % | $ 1.23 B | USA |
 |
Neoleukin Therapeutics
NLTX
|
492 K | - | - | $ 193 M | Canada |
 |
Rockwell Medical
RMTI
|
23.3 M | $ 0.92 | -0.69 % | $ 21.5 M | USA |
 |
Solid Biosciences
SLDB
|
40.8 M | $ 5.86 | -0.26 % | $ 239 M | USA |
 |
PetIQ
PETQ
|
29.1 M | - | 1.64 % | $ 400 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
1.24 M | $ 3.63 | 0.97 % | $ 4.5 M | USA |
 |
Relmada Therapeutics
RLMD
|
30.1 M | $ 4.18 | 2.83 % | $ 126 M | USA |
 |
Jupiter Wellness
JUPW
|
54.4 M | - | - | $ 33.6 M | USA |
 |
Perrigo Company plc
PRGO
|
137 M | $ 13.34 | 1.56 % | $ 1.83 B | USA |
 |
ProPhase Labs
PRPH
|
15.8 M | $ 0.12 | 2.0 % | $ 1.9 M | USA |
 |
Radius Health
RDUS
|
47.2 M | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
95.2 M | - | -4.76 % | $ 65.3 M | USA |
 |
Sundial Growers
SNDL
|
1.86 M | $ 2.07 | -6.28 % | $ 3.37 M | Canada |
 |
Veru
VERU
|
135 M | $ 2.53 | 4.47 % | $ 341 M | USA |
 |
OptiNose
OPTN
|
112 M | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
23.7 M | - | -27.8 % | $ 2.56 M | USA |
 |
cbdMD
YCBD
|
4.31 M | $ 1.35 | 10.66 % | $ 5.82 M | USA |
 |
SCYNEXIS
SCYX
|
47.9 M | $ 0.64 | -1.58 % | $ 30.6 M | USA |
 |
Tricida
TCDA
|
51.3 M | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
618 M | $ 11.17 | -8.08 % | $ 6.9 B | Canada |
 |
TherapeuticsMD
TXMD
|
10.4 M | $ 1.83 | 4.82 % | $ 19.1 M | USA |
 |
Zomedica Corp.
ZOM
|
980 M | - | -0.21 % | $ 98 M | USA |
 |
Viatris
VTRS
|
1.21 B | $ 11.76 | 0.94 % | $ 14.3 B | USA |